Akamis Bio
Blood & Organ Banks · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
245 Main St PMB 2, Cambridge, Massachuse...Phone Number
(617) 655-9767Website
www.akamisbio.comRevenue
$9 MillionIndustry
About Akamis Bio
Akamis Bio is dedicated to transforming the treatment of colorectal cancer through the development of oncolytic immunotherapies that harness the body's immune system to target tumors. The company addresses the critical unmet need for new therapies in colorectal cancer, which is the second leading cause of cancer deaths globally. Their lead clinical program, NG-350A, is currently being studied in a Phase 1b clinical trial for patients with mismatch repair proficient locally advanced rectal cancer. Akamis Bio's innovative T-SIGn therapeutics aim to deliver immune-modulating treatments directly to the tumor microenvironment.Explore more
Akamis Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Akamis Bio
Compare insights from companies similar to Akamis Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Akamis Bio Tech Stack
A closer look at the technologies used by Akamis Bio
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Akamis Bio
Sign Up For FreeTo access detailed company insights
Akamis Bio is dedicated to transforming the treatment of colorectal cancer through the development of oncolytic immunotherapies that harness the body's immune system to target tumors. The company addresses the critical unmet need for new therapies in colorectal cancer, which is the second leading cause of cancer deaths globally. Their lead clinical... Read More
